State of New Jersey Common Pension Fund D - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 342 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.71 and the average weighting 0.2%.

Quarter-by-quarter ownership
State of New Jersey Common Pension Fund D ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$5,756,253
+5.9%
47,4860.0%0.02%
+16.7%
Q2 2023$5,438,097
-16.9%
47,4860.0%0.02%
-21.7%
Q1 2023$6,544,995
+6.4%
47,4860.0%0.02%0.0%
Q4 2022$6,153,236
+11.9%
47,486
-4.5%
0.02%
+4.5%
Q3 2022$5,497,000
+43.9%
49,726
-2.4%
0.02%
+46.7%
Q2 2022$3,821,000
-4.0%
50,9710.0%0.02%
+15.4%
Q1 2022$3,982,000
-13.2%
50,9710.0%0.01%0.0%
Q4 2021$4,590,000
-5.0%
50,971
-2.4%
0.01%
-13.3%
Q3 2021$4,832,000
+22.7%
52,248
+3.1%
0.02%
+15.4%
Q2 2021$3,939,000
+6.5%
50,667
+2.1%
0.01%0.0%
Q1 2021$3,698,000
-54.6%
49,624
+3.9%
0.01%
-55.2%
Q4 2020$8,139,000
+15.8%
47,741
-4.6%
0.03%
+3.6%
Q3 2020$7,030,000
-14.9%
50,064
-2.8%
0.03%
-17.6%
Q2 2020$8,258,000
+56.1%
51,505
-4.7%
0.03%
+30.8%
Q1 2020$5,289,000
-24.2%
54,0690.0%0.03%0.0%
Q4 2019$6,977,000
+79.2%
54,069
+4.6%
0.03%
+73.3%
Q3 2019$3,894,000
-89.3%
51,700
-78.5%
0.02%
-89.0%
Q2 2019$36,468,000
+27.5%
240,0000.0%0.14%
+27.1%
Q1 2019$28,606,000
+4.8%
240,000
-4.0%
0.11%
-8.5%
Q4 2018$27,283,000
-19.6%
250,000
+19.0%
0.12%
-6.4%
Q3 2018$33,917,000
+113.8%
210,000
+75.0%
0.12%
+108.3%
Q2 2018$15,862,000120,0000.06%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Casdin Capital, LLC 1,010,330$122,472,20313.56%
Finepoint Capital LP 145,357$17,620,1768.78%
Avoro Capital Advisors LLC 4,025,000$487,910,5007.61%
Saturn V Capital Management LP 118,401$14,352,5696.01%
Ghost Tree Capital, LLC 150,000$18,183,0005.98%
Ikarian Capital, LLC 3,673$44,524,1065.36%
ACUTA CAPITAL PARTNERS, LLC 550$7,580,6505.08%
Eagle Health Investments LP 174,212$21,117,9794.65%
Boxer Capital, LLC 600,000$72,732,0003.87%
GREAT POINT PARTNERS LLC 165,200$20,025,5443.65%
View complete list of SAREPTA THERAPEUTICS INC shareholders